AF
DNA icon

Advisornet Financial’s Ginkgo Bioworks DNA Stock Holding History

Advisornet Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$845 – 2168
2023
Q4 		$845 Buy
+13
New +$796 ﹤0.01% 1933
2022
Q2 		– Sell
-4
Closed -$1K – 1932
2022
Q1 		$1K Hold
4
– – ﹤0.01% 1872
2021
Q4 		$1K Sell
4
-4
-50% -$1.9K ﹤0.01% 1910
2021
Q3 		$3K Buy
+8
New +$3.89K ﹤0.01% 1694

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisornet Financial's DNA Position: Q1 2024 in Review

Advisornet Financial sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 13 shares — an estimated $845 sold.

Advisornet Financial first reported a position in DNA in Q3 2021 and held it in 4 quarters. The position peaked at $3K in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Advisornet Financial reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 13 Ginkgo Bioworks shares in Q1 2024, an estimated $845.
  • Advisornet Financial first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 4 quarters.
  • Advisornet Financial's Ginkgo Bioworks position peaked at $3K in Q3 2021.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.